PortfoliosLab logoPortfoliosLab logo
FTXH vs. TDIV
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FTXH vs. TDIV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and First Trust NASDAQ Technology Dividend Index Fund (TDIV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FTXH achieves a 17.64% return, which is significantly higher than TDIV's 16.55% return.


FTXH

1D
-0.77%
1M
-1.43%
6M
12.69%
YTD
17.64%
1Y
49.44%
3Y*
15.53%
5Y*
9.04%
10Y*
ALL TIME*
8.02%

TDIV

1D
1.46%
1M
0.77%
6M
13.11%
YTD
16.55%
1Y
27.41%
3Y*
26.19%
5Y*
16.16%
10Y*
16.98%
ALL TIME*
15.70%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$132.42M$64.10M$22.26M
$13.43M$13.15M$15.23M

FTXH vs. TDIV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FTXH
First Trust Nasdaq Pharmaceuticals ETF
17.64%24.15%2.98%-1.41%2.55%6.14%11.73%22.13%-9.51%19.44%
TDIV
First Trust NASDAQ Technology Dividend Index Fund
16.55%25.27%24.43%36.71%-22.13%29.49%17.55%33.27%-3.18%21.95%

Correlation

The correlation between FTXH and TDIV is 0.10, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.10

Correlation (3Y)
Balances recent behavior with more history.

0.30

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.40

Correlation (All Time)
Calculated using the full available price history since Sep 22, 2016

0.41

Over the past year, the correlation between FTXH and TDIV has dropped to 0.10 - well below their long-term average of 0.41, suggesting their price drivers have been diverging.

FTXH vs. TDIV - Sectors Allocation Comparison


Sectors
FTXH
TDIV

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

15.0%

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

1.9%

Real Estate

-

-

Technology

-

83.2%

Utilities

-

-

Healthcare

FTXH
100.0%
TDIV

-

Basic Materials

FTXH

-

TDIV

-

Communication Services

FTXH

-

TDIV
15.0%

Consumer Cyclical

FTXH

-

TDIV

-

Consumer Defensive

FTXH

-

TDIV

-

Energy

FTXH

-

TDIV

-

Financial Services

FTXH

-

TDIV

-

Industrials

FTXH

-

TDIV
1.9%

Real Estate

FTXH

-

TDIV

-

Technology

FTXH

-

TDIV
83.2%

Utilities

FTXH

-

TDIV

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FTXH vs. TDIV — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

FTXH
FTXH Risk / Return Rank: 9595
Overall Rank
FTXH Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
FTXH Sortino Ratio Rank: 9595
Sortino Ratio Rank
FTXH Omega Ratio Rank: 9393
Omega Ratio Rank
FTXH Calmar Ratio Rank: 9696
Calmar Ratio Rank
FTXH Martin Ratio Rank: 9494
Martin Ratio Rank

TDIV
TDIV Risk / Return Rank: 4949
Overall Rank
TDIV Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
TDIV Sortino Ratio Rank: 5151
Sortino Ratio Rank
TDIV Omega Ratio Rank: 5050
Omega Ratio Rank
TDIV Calmar Ratio Rank: 4646
Calmar Ratio Rank
TDIV Martin Ratio Rank: 4242
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

FTXH vs. TDIV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and First Trust NASDAQ Technology Dividend Index Fund (TDIV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FTXHTDIVDifference
Sharpe ratioReturn per unit of total volatility

+1.59

Sortino ratioReturn per unit of downside risk

+2.44

Omega ratioGain probability vs. loss probability

1.48

1.23

+0.25

Calmar ratioReturn relative to maximum drawdown

6.65

1.69

+4.97

Martin ratioReturn relative to average drawdown

19.78

4.62

+15.16

FTXH vs. TDIV - Sharpe Ratio Comparison

The current FTXH Sharpe Ratio is 2.92, which is higher than the TDIV Sharpe Ratio of 1.33. The chart below compares the historical Sharpe Ratios of FTXH and TDIV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FTXH vs. TDIV - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, roughly equal to the maximum TDIV drawdown of -31.97%. Use the drawdown chart below to compare losses from any high point for FTXH and TDIV.


Loading charts...

Drawdown Indicators


FTXHTDIVDifference

Max Drawdown

Largest peak-to-trough decline

-32.11%

-31.97%

-0.14%

Max Drawdown (1Y)

Largest decline over 1 year

-7.47%

-16.34%

+8.87%

Max Drawdown (3Y)

Largest decline over 3 years

-19.51%

-23.00%

+3.49%

Max Drawdown (5Y)

Largest decline over 5 years

-19.51%

-31.97%

+12.46%

Max Drawdown (10Y)

Largest decline over 10 years

-31.97%

Current Drawdown

Current decline from peak

-2.77%

-12.34%

+9.57%

Average Drawdown

Average peak-to-trough decline

-5.76%

-4.92%

-0.84%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.51%

5.95%

-3.44%

Volatility

FTXH vs. TDIV - Volatility Comparison

The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 4.91%, while First Trust NASDAQ Technology Dividend Index Fund (TDIV) has a volatility of 5.85%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than TDIV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FTXHTDIVDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.91%

5.85%

-0.94%

Volatility (6M)

Calculated over the trailing 6-month period

12.81%

16.31%

-3.50%

Volatility (1Y)

Calculated over the trailing 1-year period

17.04%

20.69%

-3.65%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.53%

21.12%

-4.59%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.43%

21.00%

-2.57%

FTXH vs. TDIV - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is higher than TDIV's 0.50% expense ratio.


Dividends

FTXH vs. TDIV - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 1.10%, less than TDIV's 1.35% yield.


PositionTTM20252024202320222021202020192018201720162015
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.10%1.41%1.66%1.55%1.11%1.03%0.82%0.67%0.91%2.18%0.19%0.00%
TDIV
First Trust NASDAQ Technology Dividend Index Fund
1.35%1.40%1.59%1.74%2.51%1.76%2.07%2.27%2.97%2.27%2.45%2.52%

Frequently Asked Questions


FTXH and TDIV have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TDIV has higher volatility (5.85%) compared to FTXH (4.91%). In terms of maximum drawdown, FTXH dropped -32.11% vs TDIV's -31.97%.

On 5-year performance, TDIV leads with 16.16% vs 9.04% for FTXH. On fees, TDIV is cheaper at 0.50% per year. On volatility, FTXH has been the lower-risk option at 4.91%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, TDIV has performed better with a 16.16% return vs 9.04%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

TDIV is cheaper with a 0.50% expense ratio, compared with 0.60% for FTXH.

TDIV has the higher dividend yield at 1.35%, compared with 1.10% for FTXH.

FTXH is categorized as Health & Biotech Equities, while TDIV is Technology Equities. FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while TDIV tracks NASDAQ Technology Dividend Index. Their fees differ too: 0.60% for FTXH and 0.50% for TDIV.

FTXH currently has the higher Sharpe Ratio (2.92 vs 1.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FTXH and TDIV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer